Semler Scientific® to Release Third Quarter 2025 Financial Results

Core Points - Semler Scientific, Inc. has announced it will not host a conference call or provide an earnings presentation for its Q3 2025 financial results due to a pending transaction with Strive, Inc. [1] - The company is the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset, indicating a strategic shift in its financial management [3] - Semler Scientific plans to file its Quarterly Report on Form 10-Q for the period ended September 30, 2025, around November 12, 2025 [2] Company Overview - Semler Scientific is a leader in medical devices and software aimed at combating chronic diseases, with a focus on early detection and monitoring [3] - The company's flagship product, QuantaFlo®, is FDA-cleared and provides rapid point-of-care testing for diagnosing peripheral arterial disease [3] - The company intends to strategically accumulate Bitcoin using proceeds from equity and debt financings, as well as cash flows from operations [3] Transaction Details - The proposed transaction with Strive, Inc. is expected to bring strategic and financial benefits, although specific details regarding the anticipated impact on future performance have not been disclosed [4][5] - A Registration Statement on Form S-4 has been filed with the SEC to register the Class A common stock to be issued in connection with the proposed transaction [8] - Stockholders of Semler Scientific will receive a definitive Information Statement/Proxy Statement/Prospectus to seek their approval for the proposed transaction [8]